Table 3.
Univariate and multivariate analysis of progression‐free survival in PC patients (n = 45)
| Variables | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI) | P value | |
| Gender | 0.570 (0.246‐1.320) | .190 | ||
| Age (years) | 0.780 (0.371‐1.641) | .513 | ||
| Tumour location | 0.779 (0.384‐1.578) | .488 | ||
| Differentiation | 0.628 (0.329‐1.202) | .160 | ||
| Low | ||||
| High | ||||
| Moderate | ||||
| Perineural invasion | 0.339 (0.137‐0.835) | .019* | 0.422 (0.160‐1.110) | .080 |
| Yes | ||||
| No | ||||
| TNM stage (AJCC) | 2.400 (1.322‐4.357) | .004** | 1.439 (0.478‐4.338) | .518 |
| I | ||||
| II | ||||
| III | ||||
| T stage | 1.339 (0.847‐2.115) | .211 | ||
| T1 | ||||
| T2 | ||||
| T3 | ||||
| N stage | 1.872 (1.131‐3.098) | .015* | 1.218 (0.500‐2.966) | .663 |
| N0 | ||||
| N1 | ||||
| N2 | ||||
| LncNT5E expression | 2.306 (1.147‐4.638) | .019* | 2.172 (1.056‐4.468) | .035* |
| Low | ||||
| High | ||||
Cox regression analysis, * P < .05, **P < .01.
Abbreviations: 95% CI, 95% confidence interval; AJCC, American Joint Committee on Cancer; HR, hazard ratio.